688221 前沿生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)22.910-26.564-16.214-21.828-20.377
总资产报酬率 ROA (%)13.264-15.812-10.191-14.457-14.434
投入资产回报率 ROIC (%)14.308-17.132-11.013-15.867-15.742

边际利润分析
销售毛利率 (%)94.00633.21833.92728.99518.605
营业利润率 (%)76.614-216.977-155.317-286.857-421.616
息税前利润/营业总收入 (%)76.593-217.320-149.998-281.255-421.061
净利润/营业总收入 (%)76.530-217.246-155.540-287.935-421.008

收益指标分析
经营活动净收益/利润总额(%)97.85295.314137.158106.828111.148
价值变动净收益/利润总额(%)1.7400.601-41.799-5.065-5.590
营业外收支净额/利润总额(%)-0.1110.1240.1440.374-0.144

偿债能力分析
流动比率 (X)3.5402.4493.0942.9015.072
速动比率 (X)3.3252.2862.9902.7464.871
资产负债率 (%)40.10844.44337.01937.26230.670
带息债务/全部投入资本 (%)24.54824.47520.97214.0507.587
股东权益/带息债务 (%)259.210249.359321.530486.4361,009.651
股东权益/负债合计 (%)149.329125.010170.135168.373226.052
利息保障倍数 (X)1,214.1232,940.865-27.062-42.1077,917.325

营运能力分析
应收账款周转天数 (天)14.671136.027135.910156.202124.219
存货周转天数 (天)365.926235.226210.543254.308245.900